Expanding Horizons in Cancer Therapeutics Targeting the Complement Pathway

Time: 11:30 am
day: Day Two


  • Unravelling novel intricacies of complement cancer nexus will offer key insights
  • Are mechanistic models authentic predictors of clinical scenario?
  • Discussing why the selection of the right patient subsets for complement inhibition is the path forward